chlorambucil and sdx 308

chlorambucil has been researched along with sdx 308 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aleskog, A; Chao, Q; Elliott, G; Larsson, R; Leoni, L; Lindhagen, E; Nissle, S	1

Other Studies

1 other study(ies) available for chlorambucil and sdx 308

Article	Year
R-etodolac (SDX-101) and the related indole-pyran analogues SDX-308 and SDX-309 potentiate the antileukemic activity of standard cytotoxic agents in primary chronic lymphocytic leukaemia cells. Cancer chemotherapy and pharmacology, 2007, Volume: 60, Issue:4 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Chlorambucil; Doxorubicin; Drug Synergism; Etodolac; Female; Heterocyclic Compounds, 3-Ring; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Male; Middle Aged; Vincristine	2007

Article

Year

R-etodolac (SDX-101) and the related indole-pyran analogues SDX-308 and SDX-309 potentiate the antileukemic activity of standard cytotoxic agents in primary chronic lymphocytic leukaemia cells.

Cancer chemotherapy and pharmacology, 2007, Volume: 60, Issue:4

Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Chlorambucil; Doxorubicin; Drug Synergism; Etodolac; Female; Heterocyclic Compounds, 3-Ring; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Male; Middle Aged; Vincristine

2007